Ion Channels as Therapeutic Targets in High Grade Gliomas
Glioblastoma multiforme (GBM) is a lethal brain cancer with an average survival of 14–15 months even with exhaustive treatment. High grade gliomas (HGG) represent the leading cause of CNS cancer-related death in children and adults due to the aggressive nature of the tumour and limited treatment opt...
Main Authors: | Michaela Griffin, Raheela Khan, Surajit Basu, Stuart Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/3068 |
Similar Items
-
Ion Channels in Gliomas—From Molecular Basis to Treatment
by: Abdallah F. Elias, et al.
Published: (2023-01-01) -
Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas
by: Grace Hey, et al.
Published: (2023-05-01) -
The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma
by: Luigi eSforna, et al.
Published: (2015-01-01) -
Reduced Graphene Oxides Modulate the Expression of Cell Receptors and Voltage-Dependent Ion Channel Genes of Glioblastoma Multiforme
by: Jaroslaw Szczepaniak, et al.
Published: (2021-01-01) -
Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs
by: Marija Dinevska, et al.
Published: (2020-10-01)